Phase-variable Heptose I glycan extensions modulate efficacy of 2C7 vaccine antibody directed against Neisseria gonorrhoeae lipooligosaccharide

From National Research Council Canada

DOIResolve DOI:
AuthorSearch for: ; Search for: ; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for:
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Publication date
PublisherAmerican Association of Immunologists, Inc
Peer reviewedYes
NPARC number23000435
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierf87202e0-9f7a-4295-b3b1-c40cfbd5103a
Record created2016-07-15
Record modified2020-03-16
Date modified: